Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival

CNS oncology

Volumn 3, Issue 6, 2014, Pages 389-400

  Gahramanov, Seymur ^a   Varallyay, Csanad ^a   Tyson, Rose M arie ^a   Lacy, Cynthia ^a   Fu, Rongwei ^a   Netto, Joao P rola ^a   Nasseri, Morad ^a   White, Tricia ^a   Woltjer, Randy L ^a   Gultekin, Sakir H umayun ^a   Neuwelt, Edward A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ferumoxytol; glioblastoma; perfusion MRI; pseudoprogression; temozolomide

Indexed keywords

DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; BRAIN TUMOR; CHEMORADIOTHERAPY; DISEASE COURSE; FEMALE; GENETICS; GLIOBLASTOMA; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROMOTER REGION; RETROSPECTIVE STUDY;

ADULT; AGED; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DISEASE PROGRESSION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEINS;

EID: 84928111594     PISSN: None     EISSN: 20450915     Source Type: Journal    
DOI: 10.2217/cns.14.42     Document Type: Article

References (0)